Episode Details
Back to EpisodesAs U.S. measles cases reach a 35-year high, the White House is trying to overhaul the childhood vaccine schedule—including plans to split MMR. How are leading medical societies reacting?
Episode 689
Published 1 month, 2 weeks ago
Description
This episode examines controversial proposed changes to the U.S. childhood vaccine schedule amid a 35-year high in measles cases, along with medical society concerns about evidence and access. It also reviews positive phase 3 topline data for lysergide in generalized anxiety disorder, updated colorectal cancer screening guidance that now includes blood-based testing, and the CHIPS trial showing refrigerated platelets may safely extend storage to 21 days and improve access in rural and community hospitals.